“We produce cannabis where it should be produced and we sell cannabis where it should be sold – That's our thesis. That's what we've been fighting for. That’s our strategic pathway.” – Andrés Fajardo In my chat with Andrés Fajardo of Clever Leaves, we discuss how this Colombian-based company excels in the international cannabis market. Clever Leaves focuses on producing high-quality pharmaceutical-grade cannabis, backed by EU GMP-certified sites. Their global expansion journey involves navigating complex regulations and adapting to diverse markets, including Germany, Australia, Brazil, and Israel, where they prioritize medical cannabis products tailored to meet specific regulations and patient needs.